Literature DB >> 6502238

Role of surgery in hypertensive intracerebral hematoma. A comparative study of 305 nonsurgical and 154 surgical cases.

T Kanno, H Sano, Y Shinomiya, K Katada, J Nagata, M Hoshino, F Mitsuyama.   

Abstract

The indications for surgery in hypertensive intracerebral hematoma are still controversial. The reason for this may be: 1) lack of adequate and comparable data in conservative and surgical therapy from the same institution; 2) lack of adequate close follow-up monitoring over an extended period of time; or 3) lack of proper classification of hematomas for comparison of results from different institutions. The authors have treated 459 cases of hypertensive intracerebral hematoma between October, 1975, and July, 1983. The hematomas have been classified according to their mode of extension on computerized tomography. The long-term outcome was assessed on the basis of activity of daily living. Putaminal hematomas were classified as mild, moderate, severe, and very severe. In general, there was no significant difference in outcome between the surgical and nonsurgical cases; however, the outcome in the moderate and severe hematomas was found to be a little better for the surgical cases in some restricted areas. Thalamic and pontine hemorrhages were classified as mild, moderate, or severe. If the hematoma is localized to the thalamus or pons, and if it extends to the midbrain, there is no indication for surgery; however, in patients with moderate hematomas, the prognosis showed a variable outcome, and the indications for surgery were questionable. In cerebellar hematomas, the authors propose that even a hematoma with a diameter greater than 3 cm might show a good outcome with nonsurgical therapy.

Entities:  

Mesh:

Year:  1984        PMID: 6502238     DOI: 10.3171/jns.1984.61.6.1091

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  19 in total

1.  Intracerebral Hemorrhage.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-05       Impact factor: 3.598

Review 2.  Spontaneous intracerebral haemorrhage.

Authors:  A D Mendelow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-03       Impact factor: 10.154

3.  Frameless stereotactic aspiration and thrombolysis of deep intracerebral hemorrhage is associated with reduction of hemorrhage volume and neurological improvement.

Authors:  Paul Vespa; David McArthur; Chad Miller; Kristine O'Phelan; John Frazee; Chelsea Kidwell; Jeffery Saver; Sidney Starkman; Neil Martin
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

Review 4.  Intracerebral haemorrhage.

Authors:  J M MacKenzie
Journal:  J Clin Pathol       Date:  1996-05       Impact factor: 3.411

Review 5.  Dentate Update: Imaging Features of Entities That Affect the Dentate Nucleus.

Authors:  K M Bond; W Brinjikji; L J Eckel; D F Kallmes; R J McDonald; C M Carr
Journal:  AJNR Am J Neuroradiol       Date:  2017-04-13       Impact factor: 3.825

6.  The results of surgery for intracerebral hematomas.

Authors:  M Zumkeller; H G Höllerhage; M Pröschl; H Dietz
Journal:  Neurosurg Rev       Date:  1992       Impact factor: 3.042

7.  Haematoma of cavum septi pellucidi due to hypertension.

Authors:  Y Kanpolat; T Mertol
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

8.  Basal ganglia haematomas in non-comatose patients: subacute stereotactic aspiration improves long-term outcome in comparison to purely medical treatment.

Authors:  Gerhard Marquardt; Robert Wolff; Rudolf W C Janzen; Volker Seifert
Journal:  Neurosurg Rev       Date:  2004-09-29       Impact factor: 3.042

9.  Open Surgical Evacuation of Spontaneous Putaminal Hematomas: Prognostic Factors and Comparison of Outcomes between Transsylvian and Transcortical Approaches.

Authors:  Dong-Sung Shin; Seok-Mann Yoon; Sung-Ho Kim; Jai-Joon Shim; Hack-Gun Bae; Il-Gyu Yun
Journal:  J Korean Neurosurg Soc       Date:  2008-07-20

10.  Spontaneous intracerebral hemorrhage.

Authors:  R Kalff; A Feldges; H M Mehdorn; W Grote
Journal:  Neurosurg Rev       Date:  1992       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.